Eisai
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Launch date
Employees
Market cap
CAD17.3b
Enterprise valuation
CAD15.3b (Public information from Sep 2024)
Share price
JPY5805
Tokyo Japan (HQ)
Financials
Estimates*
EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 4.5b | 5.3b | 5.2b | 5.2b | 5.4b | 5.9b | 6.2b |
% growth | (7 %) | 17 % | (2 %) | - | 3 % | 9 % | 6 % |
EBITDA | 616m | 645m | 560m | 650m | 673m | 765m | 809m |
% EBITDA margin | 14 % | 12 % | 11 % | 13 % | 13 % | 13 % | 13 % |
Profit | 295m | 336m | 388m | 297m | 314m | 426m | 465m |
% profit margin | 7 % | 6 % | 7 % | 6 % | 6 % | 7 % | 7 % |
EV / revenue | 3.0x | 1.9x | 2.7x | 2.2x | 2.0x | 1.8x | 1.7x |
EV / EBITDA | 22.3x | 15.3x | 25.1x | 17.6x | 16.1x | 14.1x | 13.3x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
$25.0m Valuation: $25.0m | Acquisition | ||
Total Funding | - |
Related Content
Recent News about Eisai
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.